Four academics at Queen Mary University of London are among 349 researchers to be awarded a prestigious European Research ...
Avant Technologies Inc. ("Avant" or the "Company"), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced a newly ...
Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing ...
Profluent, a leader in frontier AI for protein design, today announced that it has entered into a strategic collaboration with Ensoma, an in vivo cellular engineering company with a mission to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results